Stakeholder Information

In this Section:

The Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS)

•  2004 Surveillance Report (June 30, 2006)
•  2003 Surveillance Report (Feb 28, 2005)
•  2002 Surveillance Report (Mar 5, 2004)

Submissions Containing Clinical Data from Studies Conducted outside of Canada

Letter: Advice to producers, veterinarians and animal nutritionists regarding the use of growth promoting anitmicrobial drug products

Notice: Post-Notice of Compliance (NOC) Changes Project

Call for Nominations to the Advisory Committee on Minor Uses / Minor Species
Letter

Call for Volunteers to participate on a Veterinary Electronic Submissions Working Group

Strategic Plan, April 2006-March 2009

Strategic Plan, April 2005-March 2008

Communiqué to Stakeholders

Communiqué to Stakeholders - Archived Communiqués

Report of the Fifth Veterinary Drugs Directorate Stakeholder Committee Meeting, Ottawa, November 3 - 4, 2004

Proposal for Ketoprofen

Veterinary Drugs Directorate Canadian Animal Health Institute Workshop Discussion of Veterinary Drug Issues
May 25 and 26, 2004

Advisory Letter to Stakeholders Regarding the Use of Hormonal Growth Implants in Veal Calves

Report of the Fourth Veterinary Drugs Directorate Stakeholder Committee Meeting, Ottawa, May 6 - 7, 2004

Call for Nominations to the Expert Advisory Committee on Antimicrobial Resistance Risk Assessment - July 2, 2004

Strategic Plan April 2004 - March 2007

Our Science, Our Health - A Report from the Health Products and Food Branch - 2003

Report of the Third Veterinary Drugs Directorate Stakeholder Committee Meeting - November 27 and 28, 2003

Notice of Intent to Adopt the Good Manufacturing Practices Guide for Active Pharmaceutical Ingredients (ICH Topic Q7A) for APIs destined for veterinary use

Drug Good Manufacturing Practices (GMP) and Establishment Licencing (EL) Enforcement Directive

Look-alike Sound-alike Health Product Names

Antimicrobial Resistance - Debunking the Myths

Report of the Consultation with Stakeholders on the development of a Risk Management Strategy on Antimicrobial Resistance Associated with Animal Use of Antimicrobial Agents

Key Messages from the second Stakeholder Committee Meeting - May 1-2, 2003

Health Canada's Veterinary Drugs Directorate Consultation with Stakeholders - Agenda

Key Messages from the first Stakeholder Committee Meeting

Doing Business with Stakeholders

VDD's First Stakeholder Workshop

Veterinary Drugs Directorate Draft Guidance - Priority Review Of Veterinary Drug Submissions